Navigation Links
MDS Nordion signs 17-year contract with Rosenergoatom
Date:10/19/2007

Contract expansion provides for increased cobalt-60 supply for the

healthcare industry

OTTAWA, Oct. 19 /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, signed a 17-year contract for the supply of cobalt-60 with Rosenergoatom, the operating utility of Russia's nuclear power plants. This contract expands upon the 2005 agreement by providing for an increased supply of cobalt-60 to MDS Nordion until 2024. As a result, MDS Nordion's overall supply will increase by approximately 30% by 2016. Cobalt-60 is primarily used for the sterilization of hospital medical supplies and pharmaceuticals to help prevent patient infection and disease by reducing harmful bacteria.

"As demand for cobalt-60 increases each year, this contract is great news for the global medical community," said Steve West, President, MDS Nordion. "It demonstrates MDS Nordion's ongoing commitment to provide customers a long-term supply to meet their growing sterilization needs."

Cobalt-60 is used worldwide to sterilize 45% of all disposable medical devices such as surgeons' gloves, syringes, sutures, and catheters. This sterilization process has been used for more than 40 years, having been proven safe, reliable and highly effective.

"Rosenergoatom plays an important role in providing a consistent supply of cobalt-60," remarks Valery Lebedev, a Deputy Director General at Rosenergoatom. "Unlike most power reactors, Rosenergoatom can harvest cobalt-60 while the reactor is in operation. This allows MDS Nordion to more closely match cobalt-60 supply to customer demand by increasing the reliability and efficiency of the overall supply chain."

About MDS Nordion

MDS Nordion (http://www.mdsnordion.com) is a world leader in medical isotopes, radiation and related technologies. It is a business unit of MDS Inc. (TSX:MDS)(NYSE:MDZ). MDS Inc. is a global life sciences company that provides market-leading products and services for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS Inc. has more than 6,200 highly skilled people in 28 countries. Find out more at http://www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.

About Rosenergoatom

Rosenergoatom was established by the decree of the President of the Russian Federation on September 7th, 1992 as the operating utility of Russia's nuclear power plants. Rosenergoatom operates all 10 state-owned Russian nuclear power facilities with a total of 31 nuclear reactors and an installed electrical capacity of 23,242 Megawatts. Rosenergoatom has also increased electric and thermal power output and recently commissioned two new power reactors; Volgodonsk-1 and Kalinin-3. More information may be found at http://www.rosenergoatom.ru/eng/.


'/>"/>
SOURCE MDS Nordion
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Filtration treatment assigns more live kidney donation
2. Depressed women show signs of earlier onset of Perimenopause
3. More signs to an approaching migraine attack
4. An Indian Bride with signs of SARS
5. Recognize Heart Attack Signs
6. Parents Should Look For Signs Of Children Becoming Overweight
7. Early Warning Signs Of Heart Disease
8. Warning Signs On Powered Baby Milk
9. Genetical Screening Can Detect Early Signs Of Multiple Sclerosis
10. Diagnosis of Alzheimers years before clinical signs emerge
11. President and Founder of National Obesity Forum Resigns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
Breaking Medicine Technology: